ALPHATEC HOLDINGS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
ALPHATEC HOLDINGS, INC. (ATEC) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$10.48 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-07-26.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-07-26
- ALPHATEC HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was $2.15M.
- ALPHATEC HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$12.63M, a 150.18% decline year-over-year.
- ALPHATEC HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$6.06M, a 186.17% decline year-over-year.
- ALPHATEC HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$9.80M.
- ALPHATEC HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $6.59M, a 129.31% increase from fiscal 2017.
- ALPHATEC HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $2.87M, a 66.29% decline from fiscal 2016.
- ALPHATEC HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $8.52M.
- ALPHATEC HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$8.51M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|
| 2019-06-30 | $2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | -$10.48M 10-Q · filed 2019-07-26 | -$16.54M derived: sum of 3 quarters · filed 2019-07-26 | -$26.34M derived: sum of 4 quarters · filed 2019-07-26 | |
| 2019-03-31 | -$12.63M 10-Q · filed 2019-05-10 | -$18.69M derived: sum of 2 quarters · filed 2019-05-10 | -$28.49M derived: sum of 3 quarters · filed 2019-05-10 | -$31.23M derived: sum of 4 quarters · filed 2019-07-26 | |
| 2018-12-31 | -$6.06M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$15.86M derived: sum of 2 quarters · filed 2019-03-29 | -$18.59M derived: sum of 3 quarters · filed 2019-07-26 | $6.59M 10-K · filed 2019-03-29 | |
| 2018-09-30 | -$9.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$12.53M derived: sum of 2 quarters · filed 2019-07-26 | $12.64M 10-Q · filed 2018-11-09 | $19.67M derived: sum of 4 quarters · filed 2019-07-26 | |
| 2018-06-30 | -$2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | $22.45M 10-Q · filed 2019-07-26 | $29.48M derived: sum of 3 quarters · filed 2019-07-26 | $25.96M derived: sum of 4 quarters · filed 2019-07-26 | |
| 2018-03-31 | $25.18M 10-Q · filed 2019-05-10 | $32.21M derived: sum of 2 quarters · filed 2019-05-10 | $28.70M derived: sum of 3 quarters · filed 2019-05-10 | $22.23M derived: sum of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | $7.03M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $3.52M derived: sum of 2 quarters · filed 2019-03-29 | -$2.95M derived: sum of 3 quarters · filed 2019-03-29 | $2.87M 10-K · filed 2019-03-29 | $2.84M 10-K · filed 2018-03-09 |
| 2017-09-30 | -$3.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$9.98M derived: sum of 2 quarters · filed 2018-11-09 | -$4.16M 10-Q · filed 2018-11-09 | -$10.28M derived: sum of 4 quarters · filed 2018-11-09 | |
| 2017-06-30 | -$6.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$645.00K 10-Q · filed 2018-08-03 | -$6.77M derived: sum of 3 quarters · filed 2018-08-03 | $9.79M derived: sum of 4 quarters · filed 2018-08-03 | |
| 2017-03-31 | $5.83M 10-Q · filed 2018-05-11 | -$303.00K derived: sum of 2 quarters · filed 2018-05-11 | $16.25M derived: sum of 3 quarters · filed 2018-05-11 | $17.82M derived: sum of 4 quarters · filed 2018-05-11 | |
| 2016-12-31 | -$6.13M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $10.43M derived: sum of 2 quarters · filed 2018-03-09 | $11.99M derived: sum of 3 quarters · filed 2018-03-09 | $8.52M 10-K · filed 2018-03-09 | |
| 2016-09-30 | $16.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $18.12M derived: sum of 2 quarters · filed 2017-11-09 | $14.65M 10-Q · filed 2017-11-09 | $15.38M derived: sum of 4 quarters · filed 2017-11-09 | |
| 2016-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$1.91M 10-Q · filed 2017-08-11 | -$1.18M derived: sum of 3 quarters · filed 2017-08-11 | $424.00K derived: sum of 4 quarters · filed 2017-08-11 | |
| 2016-03-31 | -$3.47M 10-Q · filed 2017-05-12 | -$2.74M derived: sum of 2 quarters · filed 2017-05-12 | -$1.14M derived: sum of 3 quarters · filed 2017-05-12 | -$3.64M derived: sum of 4 quarters · filed 2017-05-12 | |
| 2015-12-31 | $727.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $2.33M derived: sum of 2 quarters · filed 2017-03-31 | -$171.00K derived: sum of 3 quarters · filed 2017-03-31 | -$8.51M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$898.00K derived: sum of 2 quarters · filed 2016-11-09 | -$9.23M 10-Q · filed 2016-11-09 | -$9.67M derived: sum of 4 quarters · filed 2017-03-31 | |
| 2015-06-30 | -$2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$10.84M 10-Q · filed 2016-08-09 | -$11.27M derived: sum of 3 quarters · filed 2017-03-31 | -$10.09M derived: sum of 4 quarters · filed 2017-03-31 | |
| 2015-03-31 | -$8.34M 10-Q · filed 2016-05-06 | -$8.77M derived: sum of 2 quarters · filed 2017-03-31 | -$7.58M derived: sum of 3 quarters · filed 2017-03-31 | -$12.36M derived: sum of 4 quarters · filed 2017-03-31 | |
| 2014-12-31 | -$434.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $752.00K derived: sum of 2 quarters · filed 2017-03-31 | -$4.03M derived: sum of 3 quarters · filed 2017-03-31 | -$1.61M 10-K · filed 2017-03-31 | |
| 2014-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-10 | -$3.60M derived: sum of 2 quarters · filed 2016-02-10 | -$1.18M 10-Q · filed 2016-02-10 | $1.51M derived: sum of 4 quarters · filed 2016-03-15 | |
| 2014-06-30 | -$4.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-10 | -$2.36M 10-Q · filed 2016-02-10 | $329.00K derived: sum of 3 quarters · filed 2016-03-15 | $6.04M derived: sum of 4 quarters · filed 2016-03-15 | |
| 2014-03-31 | $2.42M 10-Q · filed 2015-05-01 | $5.11M derived: sum of 2 quarters · filed 2016-03-15 | $10.82M derived: sum of 3 quarters · filed 2016-03-15 | $4.47M derived: sum of 4 quarters · filed 2016-03-15 | |
| 2013-12-31 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $8.40M derived: sum of 2 quarters · filed 2016-03-15 | $2.05M derived: sum of 3 quarters · filed 2016-03-15 | -$896.00K 10-K · filed 2016-03-15 | |
| 2013-09-30 | $5.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$639.00K derived: sum of 2 quarters · filed 2014-10-30 | -$3.59M 10-Q · filed 2014-10-30 | -$7.29M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2013-06-30 | -$6.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$9.29M 10-Q · filed 2014-07-31 | -$12.99M derived: sum of 3 quarters · filed 2015-02-27 | -$9.07M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2013-03-31 | -$2.95M 10-Q · filed 2014-05-01 | -$6.65M derived: sum of 2 quarters · filed 2015-02-27 | -$2.73M derived: sum of 3 quarters · filed 2015-02-27 | $2.43M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2012-12-31 | -$3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $218.00K derived: sum of 2 quarters · filed 2015-02-27 | $5.38M derived: sum of 3 quarters · filed 2015-02-27 | $1.57M 10-K · filed 2015-02-27 | |
| 2012-09-30 | $3.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $9.08M derived: sum of 2 quarters · filed 2013-11-12 | $5.28M 10-Q · filed 2013-11-12 | $3.80M derived: sum of 4 quarters · filed 2014-03-20 | |
| 2012-06-30 | $5.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $1.36M 10-Q · filed 2013-08-07 | -$121.00K derived: sum of 3 quarters · filed 2014-03-20 | $262.00K derived: sum of 4 quarters · filed 2014-03-20 | |
| 2012-03-31 | -$3.81M 10-Q · filed 2013-05-02 | -$5.29M derived: sum of 2 quarters · filed 2014-03-20 | -$4.90M derived: sum of 3 quarters · filed 2014-03-20 | -$4.62M derived: sum of 4 quarters · filed 2014-03-20 | |
| 2011-12-31 | -$1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | -$1.09M derived: sum of 2 quarters · filed 2014-03-20 | -$811.00K derived: sum of 3 quarters · filed 2014-03-20 | -$2.50M 10-K · filed 2014-03-20 | |
| 2011-09-30 | $383.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $667.00K derived: sum of 2 quarters · filed 2012-11-06 | -$1.02M 10-Q · filed 2012-11-06 | -$6.71M derived: sum of 4 quarters · filed 2013-03-05 | |
| 2011-06-30 | $284.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$1.41M 10-Q · filed 2012-08-08 | -$7.09M derived: sum of 3 quarters · filed 2013-03-05 | -$16.65M derived: sum of 4 quarters · filed 2013-03-05 | |
| 2011-03-31 | -$1.69M 10-Q · filed 2012-05-08 | -$7.38M derived: sum of 2 quarters · filed 2013-03-05 | -$16.93M derived: sum of 3 quarters · filed 2013-03-05 | ||
| 2010-12-31 | -$5.69M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-05 | -$15.24M derived: sum of 2 quarters · filed 2013-03-05 | $13.08M 10-K · filed 2013-03-05 | ||
| 2010-09-30 | -$9.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $18.77M 10-Q · filed 2011-11-04 | |||
| 2010-06-30 | $28.32M 10-Q · filed 2011-08-08 | ||||
| 2009-12-31 | -$8.23M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |